National Bank of Canada
FTH

National Bank of Canada’s Faeth Therapeutics FTH Stock Holding History

National Bank of Canada’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,279
Closed -$27.3K – 3188
2024
Q3 		$27.3K Buy
2,279
+1,779
+356% +$21.7K ﹤0.01% 1865
2024
Q2 		$5.9K Buy
+500
New +$10.4K ﹤0.01% 2234

Other funds holding FTH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

National Bank of Canada's FTH Position: Q4 2024 in Review

National Bank of Canada sold out of Faeth Therapeutics (FTH) in Q4 2024, closing a stake of 2,279 shares — an estimated $27.3K sold.

National Bank of Canada first reported a position in FTH in Q2 2024 and held it in 2 quarters. The position peaked at $27.3K in Q3 2024. 23 funds tracked by Wall St. Rank hold FTH as of Q4 2024.

  • National Bank of Canada reported no remaining Faeth Therapeutics position as of Q4 2024 after selling out during the quarter.
  • National Bank of Canada sold 2,279 Faeth Therapeutics shares in Q4 2024, an estimated $27.3K.
  • National Bank of Canada first reported a position in Faeth Therapeutics in Q2 2024 and held it in 2 quarters.
  • National Bank of Canada's Faeth Therapeutics position peaked at $27.3K in Q3 2024.
  • 23 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q4 2024.

Based on National Bank of Canada's 13F filing for Q4 2024, filed 12 Feb 2025.